Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Investing Activities (2023 - 2025)

Rallybio's Cash from Investing Activities history spans 3 years, with the latest figure at $29.2 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 31.62% year-over-year to $29.2 million; the TTM value through Sep 2025 reached $41.8 million, down 19.63%, while the annual FY2024 figure was $33.5 million, 21.09% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was $29.2 million at Rallybio, up from $3.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $29.2 million in Q3 2025 and bottomed at -$1.6 million in Q4 2024.
  • The 3-year median for Cash from Investing Activities is $6.2 million (2023), against an average of $9.5 million.
  • The largest YoY upside for Cash from Investing Activities was 623.29% in 2024 against a maximum downside of 109.3% in 2024.
  • A 3-year view of Cash from Investing Activities shows it stood at $16.9 million in 2023, then crashed by 109.3% to -$1.6 million in 2024, then surged by 1958.04% to $29.2 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Cash from Investing Activities are $29.2 million (Q3 2025), $3.0 million (Q2 2025), and $11.1 million (Q1 2025).